source
- NewLimit raises $682M to pursue new class of anti-aging drugsNewLimit, a biotech startup based in South San Francisco, announced it secured $682 million in funding. The round was led by venture firms including Kleiner Perkins, Founders Fund, Dimension Capit…
- SonoThera secures $186 million to advance non-viral gene-therapy platformSonoThera, the winner of the Endpoints 11 2026 competition, announced a fresh financing round to push its non-viral gene-therapy technology forward. The company raised a total of $186 million, wit…